---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-013632"
form_type: "8-K"
ticker: "TCMD"
cik: "0001027838"
company_name: "TACTILE SYSTEMS TECHNOLOGY INC"
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T03:39:44.741147+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Tactile Medical Q2 revenue $68.3M (+15% YoY); narrows net loss to $0.1M; raises FY23 guidance

## Summary
- Revenue $68.3M (+15% YoY); lymphedema +16%, airway clearance +4%.
- Net loss $0.1M ($0.00/diluted) vs loss $4.6M ($0.23/diluted) in Q2 2022.
- Adjusted EBITDA $6.1M, up from $1.7M; cash $63.2M; debt $47.5M.
- FY23 revenue guidance raised to $274M-$278M (prev $271M-$275M, +11%-13% YoY).
- Sherri Ferstler appointed SVP of Sales (Jul 31); credit agreement amended to extend maturity.

## SEC filing metadata
- accession: 0001558370-23-013632
- form_type: 8-K
- ticker: TCMD
- cik: 0001027838
- company_name: TACTILE SYSTEMS TECHNOLOGY INC
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1027838/000155837023013632/0001558370-23-013632-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1027838/000155837023013632/tcmd-20230807x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-013632
- JSON: https://secwatch.observer/filing/0001558370-23-013632.json
- Plain text: https://secwatch.observer/filing/0001558370-23-013632.txt

## Key facts
- Earnings Releases
  TACTILE SYSTEMS TECHNOLOGY INC reported six months ended June 30, 2023 results: revenue $127.2 million, net income Net loss for the six months ended June 30, 2023, was $2.0 million, or $0.09 per diluted share.
  - Period: six months ended June 30, 2023
  - Revenue: $127.2 million
  - Net income: Net loss for the six months ended June 30, 2023, was $2.0 million, or $0.09 per diluted share
  - Result: reported results
  source text: Total revenue for the six months ended June 30, 2023, increased $19.6 million, or 18.2%, to $127.2 million, compared to $107.6 million for the six months ended June 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1027838/000155837023013632/0001558370-23-013632-index.htm
- Earnings Releases
  TACTILE SYSTEMS TECHNOLOGY INC reported second quarter ended June 30, 2023 results: revenue $68.3 million, net income Net loss of $0.1 million, or $0.00 per diluted share. Guidance raised.
  - Period: second quarter ended June 30, 2023
  - Revenue: $68.3 million
  - Net income: Net loss of $0.1 million, or $0.00 per diluted share
  - Guidance: raised
  - Result: reported results
  source text: Tactile Medical for future growth and value creation.” Second Quarter 2023 Financial Results Total revenue in the second quarter of 2023 increased $8.7 million, or 14.6%, to $68.3 million, compared to $59.6 million in the second quarter of 2022. The increase in total revenue was attributable to an increase of $8.4 million, or 16.2%, in sales and rentals of the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1027838/000155837023013632/0001558370-23-013632-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.